Clinical Trial Update: Zoledronic Acid in Cystic Fibrosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating zoledronic acid for cystic fibrosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Papworth Hospital NHS Foundation Trust | Conditions: Cystic Fibrosis | Phase 4 | Status: WITHDRAWN